Rasa has launched two coffee alternative mixes with adaptogenic herbs and mushrooms instead of caffeine, the Classic Rasa and Café Rasa.
Rasa CEO and founder, Lopa van der Mersch, said Classic Rasa, which is made of roasted chicory, burdock root, and date seed to create a dark, rich, and sweet blend, is the most coffee-like alternative out there.
It also has adaptogens: red Asian ginseng, cordyceps, rhodiola, gynostemma, shatavari, and maca.
Meanwhile, Café Rasa blends freeze-fried coffee from Chiapas, Mexico, with adaptogens that are said to soften coffee’s downsides whilst supplementing caffeine’s fatigue-fighting abilities.
According to van der Mersch, the two new mixes open new channels of distribution and provide everyone with the opportunity to drink Rasa.
Co-founder, Ben LeVine, added that their process includes brewing the herbs over several hours like a standard decoction, then drying it and granulating it to produce a supremely delicious, dissolvable, and bioavailable mix.


Asian Currencies Mixed as Yen Weakens, Dollar Holds Firm
Iran Tanker Attacks Surge as Hormuz Oil Flows Near Prewar Levels
Gold Prices Rise as Dollar Weakens, Treasury Yields Ease
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Wall Street Rises as Oil Prices Ease, Nasdaq Hits Record
Intel Reaffirms Role in Elon Musk’s Terafab Chip Project
Zcash Privacy Demand Rises as AI Exposes Bitcoin Transactions
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Rapidus Seeks Chip Customers as Japan Pushes 2nm Semiconductor Revival
Evernorth XRPN Nasdaq Listing Delayed to October 12
Kalshi Withdraws PEPE Perpetual Futures Filing
World Bank Raises South Asia Growth Forecast to 6.9%
Why have so few atrocities ever been recognised as genocide?
OKX Raises Fresh Funding at $25 Billion Valuation
New York Declares Measles Disaster Emergency as Cases Surge
FDA Weighs Safety Standards for Psychedelic Therapies 



